Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care
PICNIC
A Phase III Study of Peripherally Inserted Versus Centrally Inserted Central Venous Catheters in the Neurological Intensive Care Unit
1 other identifier
interventional
80
1 country
2
Brief Summary
The investigators aim to compare the complications between centrally and peripherally inserted central venous catheters in neurological intensive care unit patients. The study hypothesis is that peripherally inserted catheters will have more cumulative complications due to venous thrombosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jan 2012
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2011
CompletedFirst Posted
Study publicly available on registry
December 20, 2011
CompletedStudy Start
First participant enrolled
January 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedAugust 4, 2015
August 1, 2015
3.5 years
December 13, 2011
August 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The composite of death or catheter related large vein thrombosis
15 days
Secondary Outcomes (1)
Cumulative catheter related complications until discharge
30 days
Study Arms (2)
PICC line (Peripherally)
EXPERIMENTALplacement of a picc line
CICVC (central insertion)
ACTIVE COMPARATORplacement of a centrally inserted central venous catheter
Interventions
Placement of a peripherally inserted central venous catheter
Eligibility Criteria
You may qualify if:
- all patients age \> 18, admitted to the neurological ICU who are require a de novo central venous catheter as standard of care and in which a double lumen 5f PICC or CICVC (triple lumen, 7f) are acceptable for the indication.
- the patients must be expected to survive and need a central venous catheter for at least 7 days.
You may not qualify if:
- prisoner
- age \< 18
- expected to die or have care withdrawn prior to ICU day 7
- requiring an emergent central venous catheter
- suspected bacteremia
- recent central venous catheter within the last 30 days
- patients who are not a candidate for bedside placement of either a CICVC or PICC line
- patients with renal insufficiency with creatinine level greater than 3.0 mg/dL (265.2 m mol/L) or who were undergoing hemodialysis
- patients requiring a central venous catheter for prolonged antibiotic therapy\\
- patient who the treating clinician feels clearly needs one particular type of catheter over the other
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Michigan Health System
Ann Arbor, Michigan, 48103, United States
Bronson Methodist Hospital
Kalamazoo, Michigan, 49001, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey J Fletcher, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study PI
Study Record Dates
First Submitted
December 13, 2011
First Posted
December 20, 2011
Study Start
January 1, 2012
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
August 4, 2015
Record last verified: 2015-08